Back to rankings

Allianz SE (ALIZF)

NEUTRAL
Financial ServicesInsurance - DiversifiedGermany

Fundamental

65

Price

$510.00

Market Cap

$195.01B

Part 1 · What the company is worth

Overview

Allianz sells insurance and manages investments. Its Property-Casualty arm insures cars, homes and businesses against accidents and damage; its Life/Health arm sells savings and protection policies, often bundled with long-term investment products; and its Asset Management arm, which includes PIMCO, invests money for institutional and retail clients worldwide in exchange for a fee, largely independent of Allianz's own insurance results.

How it makes money

The insurance businesses collect premiums upfront and pay claims later, aiming for an underwriting profit and earning investment income on the funds held in between. The asset management business instead earns fees on the assets it manages for others, a stream of income that does not depend on Allianz's own underwriting results and grows or shrinks with market values and net client inflows.

Revenue by segment

Property-Casualty46.4%

Insurance for cars, homes, businesses and other property and liability risks; the largest segment by business volume.

Life/Health45.3%

Savings, protection and health insurance policies, many with a long-term investment component tied to interest rates.

Asset Management4.5%

Fee-based investment management for institutional and retail clients, including through PIMCO; the smallest segment by revenue but a distinct, less capital-intensive business.

Competitive moat

Scale · Narrow

A global brand, a large capital base and decades of claims data give Allianz pricing and distribution advantages that smaller insurers cannot match easily. But insurance is not a business with high switching costs for the customer, and Allianz competes against other large composite insurers with similar scale in most of its markets.

What drives demand

Defensive

Most insurance policies are renewed out of necessity — cars must be insured, mortgages often require it — so premium volumes hold up reasonably well through economic cycles. The asset management business is more cyclical, since fee income moves with the market value of the assets it manages.

Key risks

  • Underwriting risk — The group's capital requirements under its Solvency II model are driven in significant part by underwriting risk — the chance that claims, whether from catastrophes or from life and health policies, come in higher than priced for.
  • Market risk on invested assets — Premiums held to cover future claims and long-term life savings guarantees are invested in bonds, equities and other assets, so interest-rate and capital-market swings affect both investment income and the value of liabilities.
  • Credit and counterparty risk — The group is exposed to the risk that bond issuers, reinsurers or other counterparties in its investment and reinsurance arrangements fail to meet their obligations, tracked as a distinct capital-requirement category.

The case for

Buyers argue that a record operating profit and growth across all three segments show the diversified insurance-plus-asset-management model working, that scale gives Allianz pricing discipline smaller rivals cannot match, and that a fee-based asset management arm adds a stream of income that does not depend on underwriting results.

The case against

Sellers fear that a large, long-duration life and health book leaves Allianz exposed to interest-rate swings over decades, that a run of severe natural catastrophes could push underwriting losses well above pricing assumptions, and that regulatory capital requirements under Solvency II could tighten in ways that constrain how the group deploys capital.

Written by the editors, published on August 18, 2026

Direct competitors

Who this company fights with for the same customers

Generated on August 23, 2026 with claude-opus-5 — shared with all users

AXA S.A.CS

Europe's other full-line insurance group, selling property & casualty, life and health cover to retail and corporate customers in the same core markets of France, Germany, Italy and Asia.

Zurich Insurance Group AGZURN

Competes head-on for global corporate and commercial property & casualty programmes, the segment Allianz serves through Allianz Commercial, as well as for retail motor and home business in Europe.

Assicurazioni Generali S.p.A.G

Fights for the same life and property & casualty policyholders across continental Europe, above all in Italy, Germany and Central and Eastern Europe, through a comparable agent-led distribution network.

Münchener Rückversicherungs-Gesellschaft AG (Munich Re)MUV2

Through its ERGO primary-insurance arm it competes for the same German life, health and property customers Allianz depends on, while both groups also underwrite large industrial risks.

Chubb LimitedCB

Rival underwriter of large commercial, specialty and high-net-worth property & casualty risks, bidding for the same multinational corporate accounts as Allianz Commercial.

Balance Sheet & Liquidity

Revenue

$132.70B

Trailing 12 months to the last reported quarter — estimated from per-share metrics

Net Income

$18.27B

Trailing 12 months to the last reported quarter — estimated from per-share metrics

Free Cash Flow

$9.31B

Total Equity

$73.70B

Total Liabilities

$33.71B

Current Ratio

1.51

Interest Coverage

-

Debt/EBITDA

1.57

Earnings Per Share

Revenue & Net Income

Free Cash Flow

Income Breakdown

Historical statement

Margins over time

Debt over time

How heavy the debt is

Growth grid

Growth — Revenue

Fair Value Estimation

Fairly Valued

Fair Value

$576.57

Current Price

$510.00

Margin of Safety

+11.5%

Fair Value Range

$374.77 - $778.37

Estimation Methods

Analyst Target:-
DCF:$673.78
PE-based:$515.48
Graham Growth:$978.14
EPV:$169.45
Analyst Consensus:Buy (14B / 9H / 2S)
Last Earnings Surprise:-9.17%

Valuation Metrics

P/E Ratio

10.59

ROE

19.6%

P/B Ratio

2.94

P/FCF

20.95

Gross Margin

25.0%

ROIC

12.0%

Profitability Radar

Value Creation (Economic Moat)

ROIC

12.0%

WACC

7.2%

ROIC − WACC

+4.8 pp

ROIC exceeds the cost of capital — the company is creating value for shareholders.

Fundamental Analysis Criteria

Passed (15)

  • Price CAGR 12.16%
  • ROIC 12.0%
  • P/FCF 20.95
  • P/B Ratio 2.94
  • Debt/Equity ratio
  • Operating Margin 5.3%
  • Positive Free Cash Flow
  • Current Ratio
  • Debt/EBITDA
  • ROE 28.1%
  • Analyst Consensus 56% Buy
  • Earnings Surprise avg 8.8%
  • PEG Ratio 0.80
  • Earnings Quality (OCF/NI) 2.78
  • Net Margin Trend 5.8% vs 5.5%

Failed (6)

  • Gross Margin 25.0%
  • CapEx intensity
  • Price below Graham Number
  • DCF valuation (Overvalued)
  • Revenue Growth 5Y -5.2%
  • Piotroski F-Score 2/9

Unavailable (6)

  • EPS data insufficient
  • Dividend Payout NaN%
  • Interest Coverage
  • Return on Tangible Assets
  • Low reliance on intangibles
  • Share Dilution (missing shares data)

Piotroski F-Score

2/9

Serious financial concerns

score
criteria

Earnings Quality

2.78

High quality: earnings backed by cash

Share Dilution

-

Buying back shares. Shareholder friendly

Governance

Executive Team

NameTitleAge
Mr. Oliver BateChairman of the Management Board & CEO60
Ms. Claire-Marie Thomas Coste-LepoutreCFO & Member of Management Board50
Dr. Gunther ThallingerMember of the Management Board53
Dr. Klaus-Peter RohlerMember of the Management Board61
Madam Renate WagnerMember of the Management Board49
Mr. Christopher George TownsendMember of the Management Board57
Dr. Barbara Karuth-Zelle Ph.D.COO & Member of the Management Board55
Dr. Andreas Georg WimmerMember of the Management Board51
Ms. Sirma Gencheva BoshnakovaMember of the Management Board54
Euler HermesMember of the Management Board-

Audit Risk

9

Board Risk

3

Compensation Risk

3

Shareholder Rights Risk

1

Part 2 · The price and when to enter

This part won't tell you whether the company is worth owning: it helps you choose when to buy it, once the fundamentals have convinced you. Inside: technical analysis, potential, historical drawdowns, gamma exposure.

Latest News

Recent headlines for ALIZF, sourced from Markets Gazette.

No recent news for ALIZF.